Compile statistics related to marketing actions and campaigns, collecting and coordinating monthly reports. Monitor and analyse the results of these reports to assess the effectiveness of marketing efforts. The method used to determine tumor status (T), lymph node (LN) status (N), and systemic status (M) should be noted (clinical, imaging, pathological) [IV, A]. Work with consultants and suppliers to create visually engaging materials, including infographics, printed materials, and videos in line with ESTRO branding.

Opioids are the main analgesics for the treatment of moderate to severe cancer-related pain; the first option is oral morphine [I, A]; but other opioids and alternative routes (transdermic, subcutaneous) can be required in specific situations (ie, intestinal obstruction, problems with swallowing, renal failure) [III, B]. Pathological confirmation may be obtained by colposcopy oriented biopsy or small cone (appropriate only during the first trimester of pregnancy, endocervical curettage is contraindicated) [IV, C]. Future-proofing radiotherapy access. The fine balance between preferences and sustainability / Our resources are limited! An insight on optimising radiotherapy resources for the future / Speed Dating / Optimal health for all together - What do staff and patients need to achieve this? / The possibility to improve patient care is endless. (Some) initiatives to integrate into radiotherapy departments of the future / Young Networking Event & Quiz (including the Elsevier Young Investigator Awards Presentation)In case of suspected tumor persistence, recurrence or second primary cancer, histological verification is strongly recommended [V, A].

Radical surgical approaches such as radical hysterectomy, trachelectomy or parametrectomy represent overtreatment and should not be performed for patients with T1a1 disease [IV, D]. Dyba T, Randi G, Bray F et al (2021) The european cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer 157:308–47 Weight gain, severe mood swings, PMS symptoms and even gynecomastia ("man boobs") can be a result of xeno-estrogens or imbalances between estrogen and other hormones for both men and women.The type of radical hysterectomy (extent of parametrial resection, type A-C2) should be based on the presence of prognostic risk factors identified preoperatively such as tumor size, maximum stromal invasion, and LVSI, which are used to categorize patients at high, intermediate, and low risk of treatment failure. A complete description of the template used for radical hysterectomy should be present in the surgical report. The 2017 modification of the Querleu-Morrow classification is recommended as a tool [IV, A]. Platinum-based chemotherapy±bevacizumab is recommended for chemo-naïve, medically fit patients with recurrent/metastatic disease. Carboplatin/paclitaxel and cisplatin/paclitaxel are the preferred regimens [I, A]. Early palliative care, integrated with oncological treatments, should be offered by the clinical team to all the patients diagnosed with advanced cervical cancer for managing symptoms and improving quality of life. A multidisciplinary approach must be included in the care plan with discussion and planning for specific treatment of these symptoms [IV, A]. The prognostic factors should be evaluated carefully and balanced in relation to the major morbidity caused by the treatment [IV, A]. LN assessment should be performed as the first step of surgical management [IV, A]. Minimally invasive surgery is an acceptable approach for LN staging [IV, B].